Biodesix, Streck Form Partnership on In Vitro Diagnostics
The agreement will help both companies pursue FDA approval for their diagnostic testing services and specimen collection products.
Read MorePosted by | Apr 6, 2020 | Molecular Diagnostics |
The agreement will help both companies pursue FDA approval for their diagnostic testing services and specimen collection products.
Read MorePosted by | Mar 31, 2020 | Computing Systems, Information Technology, Middleware & Software |
Qlucore is expanding its bioinformatics software business into precision medicine and precision diagnostics.
Read MorePosted by Steve Halasey | Feb 27, 2020 | Sepsis, Uncategorized |
Sperzel succeeds John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read MorePosted by Steve Halasey | Jan 10, 2020 | Breast, Lung Cancer, Sepsis |
T2 Biosystems has announced the appointment of diagnostics industry veteran John Sperzel as president and chief executive officer, succeeding John McDonough, who will continue with his board leadership role, serving as nonexecutive chairman.
Read MorePosted by | Dec 31, 2019 | Lung Cancer |
Caris Life Sciences’ Molecular Intelligence GPS score aids in the characterization of cancer of unknown primary and atypical cases, while also identifying appropriate treatment options.
Read More